Y Jin, X Lu, Y Liu, L Su, C Bao, H Guo - Cytotechnology, 2024 - Springer
CD8+ T cells are the primary mediators of anticancer immunity, and modulation of the CD8+
T cell response has been a central focus of immunotherapy to treat cancer. When CD8+ T …